US20230363809A1 - Methods of treating sacral insufficiency fractures and devices for performing same - Google Patents
Methods of treating sacral insufficiency fractures and devices for performing same Download PDFInfo
- Publication number
- US20230363809A1 US20230363809A1 US17/744,510 US202217744510A US2023363809A1 US 20230363809 A1 US20230363809 A1 US 20230363809A1 US 202217744510 A US202217744510 A US 202217744510A US 2023363809 A1 US2023363809 A1 US 2023363809A1
- Authority
- US
- United States
- Prior art keywords
- trocar
- access device
- stylet
- central passage
- end portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 50
- 208000013201 Stress fracture Diseases 0.000 title claims abstract description 26
- 239000000463 material Substances 0.000 claims abstract description 48
- 238000011282 treatment Methods 0.000 claims abstract description 23
- 210000003131 sacroiliac joint Anatomy 0.000 claims abstract description 8
- 210000003484 anatomy Anatomy 0.000 claims description 20
- 230000013011 mating Effects 0.000 claims description 20
- 206010017076 Fracture Diseases 0.000 claims description 19
- NOQGZXFMHARMLW-UHFFFAOYSA-N Daminozide Chemical compound CN(C)NC(=O)CCC(O)=O NOQGZXFMHARMLW-UHFFFAOYSA-N 0.000 claims description 17
- 208000010392 Bone Fractures Diseases 0.000 claims description 15
- 238000002594 fluoroscopy Methods 0.000 claims description 15
- 210000003692 ilium Anatomy 0.000 claims description 8
- 238000001356 surgical procedure Methods 0.000 description 8
- 210000000988 bone and bone Anatomy 0.000 description 3
- 239000004568 cement Substances 0.000 description 3
- 238000012148 non-surgical treatment Methods 0.000 description 3
- 206010015866 Extravasation Diseases 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000036251 extravasation Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 208000029725 Metabolic bone disease Diseases 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 206010049088 Osteopenia Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- XQZXYNRDCRIARQ-LURJTMIESA-N iopamidol Chemical compound C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I XQZXYNRDCRIARQ-LURJTMIESA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3472—Trocars; Puncturing needles for bones, e.g. intraosseus injections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/88—Osteosynthesis instruments; Methods or means for implanting or extracting internal or external fixation devices
- A61B17/8802—Equipment for handling bone cement or other fluid fillers
- A61B17/8805—Equipment for handling bone cement or other fluid fillers for introducing fluid filler into bone or extracting it
- A61B17/8811—Equipment for handling bone cement or other fluid fillers for introducing fluid filler into bone or extracting it characterised by the introducer tip, i.e. the part inserted into or onto the bone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/88—Osteosynthesis instruments; Methods or means for implanting or extracting internal or external fixation devices
- A61B17/8802—Equipment for handling bone cement or other fluid fillers
- A61B17/8805—Equipment for handling bone cement or other fluid fillers for introducing fluid filler into bone or extracting it
- A61B17/8819—Equipment for handling bone cement or other fluid fillers for introducing fluid filler into bone or extracting it characterised by the introducer proximal part, e.g. cannula handle, or by parts which are inserted inside each other, e.g. stylet and cannula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
- A61B17/1604—Chisels; Rongeurs; Punches; Stamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B2017/564—Methods for bone or joint treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/376—Surgical systems with images on a monitor during operation using X-rays, e.g. fluoroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30988—Other joints not covered by any of the groups A61F2/32 - A61F2/4425
- A61F2002/30995—Other joints not covered by any of the groups A61F2/32 - A61F2/4425 for sacro-iliac joints
Definitions
- the disclosures made herein relate generally to treatment techniques for spinal and pelvic ailments and, more particularly, to methods of treating sacral insufficiency fractures and devices for performing same.
- Sacral insufficiency fractures generally involve a non-displaced fracture of the sacrum. They are typically very painful, causing site-specific pain and leading to significant debility in patients. The underlying cause for such fractures is poor bone quality such as from a result of osteoporosis or osteopenia. Accordingly, sacral insufficiency fractures are most often seen in the elderly population. Although this type of fracture is often the result of trauma, lifting, or excessive activity, they also may occur with no clear inciting event.
- Non-surgical treatment for sacral insufficiency fractures involves prolonged bedrest, with the understanding that the fractures will eventually heal on their own.
- prolonged bedrest has well-documented negative effects, including complications such as blood clots, muscle wasting, deconditioning, etc.
- An intermittently-used surgical treatment for sacral insufficiency fractures has been sacroplasty, which involves a radiologist performing a procedural variation of the more widely used vertebroplasty or kyphoplasty procedures in a CT-guided setting. Vertebroplasty and kyphoplasty procedures are used to treat vertebral body fractures.
- sacroplasty generally requires significant planning which has been known to delay treatment, make it logistically/financially unviable, or both.
- Embodiments of the disclosures made herein are directed to methods of surgical treatment for sacral insufficiency fractures and devices used in such methods. Beneficially, these treatment methods are more attainable for surgeons already performing sacroiliac joint (SJ) fusions because it employs familiar radiological landmarks and because it is a more efficient technique for performing sacroplasty.
- SJ sacroiliac joint
- treatment methods in accordance with the disclosures made herein utilize only fluoroscopy and not a computerized tomography (CT) scanner or other type of imaging technology, the ability to schedule procedures for such treatment methods in an operating room (OR) or a procedure suite are much more cost-effective and are logistically much simpler—i.e., does not require services of a radiologist and CT scanner.
- CT computerized tomography
- a method for treatment of a sacral insufficiency fracture comprises a plurality of steps.
- a step is performed for placing an access device within a patient. Such placing of the access device includes causing a distal end portion of the access device to traverse through a sacroiliac joint of the patient and to traverse into the patient's sacrum until the distal end portion of the access device is within a region of the sacrum where a sacral insufficiency fracture is located.
- a step is performed for delivering bonding material though a portion of the access device into the sacrum at the region thereof where the sacral insufficiency fracture is located.
- an access device adapted for treatment of a skeletal fracture comprises a trocar having a central passage and a stylet having a portion thereof deposed within a central passage of the trocar.
- the distal end portion of the access device includes a distal end portion of the trocar.
- the stylet includes engagement structures that engage mating engagement structures of the trocar for maintaining the stylet in a fixed axial position within the central passage of the trocar when the mating engagement structures are in an engaged configuration and enabling the stylet to be removed from within the central passage of the trocar when the mating engagement structures are in a disengaged configuration.
- placing the access device is performed using only fluoroscopy for visualizing guidance of the access device.
- the method for treatment of the sacral insufficiency fracture further comprises identifying an intended entry point for the access device.
- identifying the intended entry point includes determining a dorsal sacral line and a superior alar line in regard to the patient's pelvic anatomy.
- the intended entry point is approximately 2-4 centimeters inferior to the dorsal sacral line and approximately 2-4 centimeters posterior to the superior alar line.
- delivering the bonding material includes attaching a bonding material delivery device to a trocar of the access device and using the bonding material delivery device to inject the bonding material into the region of the sacrum where the sacral insufficiency fracture is located.
- the access device includes mating engagement structures that maintaining the stylet in a fixed axial position within the central passage of the trocar when the mating engagement structures are in an engaged configuration and enabling the stylet to be removed from within the central passage of the trocar when the mating engagement structures are in a disengaged configuration.
- placing the access device includes maintaining the trocar and stylet in the engaged configuration and removing the stylet from within the central passage of the trocar includes manipulating the trocar and stylet to be in the disengaged configuration.
- the access device includes a trocar and a stylet having a portion thereof deposed within a central passage of the trocar, the distal end portion of the access device includes a distal end portion of the trocar and delivering the bonding material includes removing the stylet from within the central passage of the trocar after placing an access device and attaching a bonding material delivery device to a proximate end portion of the trocar removing the stylet from within the central passage of the trocar.
- the method for treatment of the sacral insufficiency fracture further comprises inserting the stylet back into the central passage after injecting the bonding material and removing the access device from the patient after the bonding material has fully or partially cured.
- the method for treatment of the sacral insufficiency fracture further comprises urging the distal end portion of the access device into fixed engagement with an ilium wing of the patient's pelvic anatomy and, in response to attaining fixed engagement with the ilium wing of the patient's pelvic anatomy, assessing at least one of inlet and outlet fluoroscopic views of the patient's pelvic anatomy to verify an intended trajectory of the distal end portion of the access device, and while viewing the distal end portion of the access device under live fluoroscopy, further urging the distal end portion of the access device until the distal end portion of the access device traverses the sacroiliac joint and protrudes into the sacrum.
- the access device adapted for treatment of a skeletal fracture further comprises an adaptor configured for enabling attachment to the bonding material delivery device to the trocar to allow the bonding material to be delivered to an operative site through the central passage of the trocar.
- the adapter is a threaded mounting body integral with a handle of the trocar.
- FIG. 1 is a perspective view showing an access device in accordance with one or more embodiment of the disclosures made herein;
- FIG. 2 is an exploded view of the access device of FIG. 1 ;
- FIG. 3 is a partial view of the access device of FIG. 1 , where a stylet unit (i.e., stylet and attached handle) is in a release configuration relative to a trocar unit (i.e., a trocar and attached handle);
- a stylet unit i.e., stylet and attached handle
- a trocar unit i.e., a trocar and attached handle
- FIG. 4 is a partial view of the access device of FIG. 1 , where the stylet unit is in an engaged configuration relative to the trocar unit;
- FIG. 5 is a perspective view of the trocar unit
- FIG. 6 is a cross-sectional view taken along the line 6 - 6 in FIG. 5 ;
- FIG. 7 is an illustrative view showing a patient in a prone position on an operating table
- FIG. 8 is a lateral view of a pelvic portion of the patient's anatomy (i.e., pelvic anatomy);
- FIG. 9 is an inlet view of the pelvic portion of the patient's anatomy
- FIG. 10 is an outlet view of the pelvic portion of the patient's anatomy
- FIG. 11 is the lateral view of the pelvic portion of the patient's anatomy with access device entry point reference information shown;
- FIG. 12 is the inlet view of the pelvic portion of the patient's anatomy showing an SI fracture and an access device shown in a partially placed position;
- FIG. 13 is the outlet view of the pelvic portion of the patient's anatomy showing the SI fracture and the access device shown in a partially placed position.
- embodiments of the disclosures made herein are directed to methods of surgical treatment for sacral insufficiency (SI) fractures and devices used in such methods.
- SI sacral insufficiency
- treatment methods in accordance with embodiments of the disclosures made herein preferably utilize only fluoroscopy, scheduling procedures for such treatment methods in an operating room (OR) or a procedure suite may be much more cost-effective and logistically much simpler. Accordingly, treatment methods in accordance with embodiments of the disclosures made herein allow for more readily-available sacral fracture treatment for patients and ultimately allow faster alleviation of suffering and lead to better outcomes both short-term and long-term.
- Treatment methods in accordance with embodiments of the disclosures made herein may involve use of an access device 100 comprising a trocar unit 105 and a stylet unit 110 , as shown in FIGS. 1 - 6 .
- the trocar unit 105 has a trocar handle 124 and a trocar 125 attached to the trocar handle 124 .
- the stylet unit 110 has a stylet handle 129 and a stylet 130 attached to stylet handle 129 .
- a central passage 135 extends through the trocar handle 124 and the trocar 125 .
- the stylet 130 is engageable within the central passage 135 .
- the stylet 130 has a length to where a distal end portion 150 of the stylet 130 extends beyond a distal end portion 155 of the trocar 125 when the trocar unit 105 and the stylet unit 110 are engaged with each other, as shown in FIG. 1 ).
- the trocar unit 105 is designed to allow access to deeper elements of the sacrum and better control of the trocar 125 at deeper depths.
- the trocar 125 may be about an 11 gauge in size with a length of about 9 inches.
- the trocar handle 124 and the stylet handle 129 may be jointly configured to selectively allow the trocar unit 105 and the stylet unit 110 to be adjoined with each other (e.g., for inhibiting unrestricted axial displacement of the stylet 125 relative to the trocar unit 105 ) and to be separated from each other.
- the trocar handle 124 may have one or more stylet engaging elements 140 (e.g., protruding members) that may be selectively engage with one or more trocar engaging elements 145 (e.g., a recess or channel) of the stylet handle 129 .
- the stylet engaging elements 140 are engagement structures of the trocar 125 and the trocar engaging elements 145 are engagement structures of the stylet 130 .
- the trocar handle 124 is in a disengaged configuration D relative to the stylet handle 129 , the one or more stylet engaging elements 140 are disengaged from the one or more trocar engaging elements 145 (i.e., the mating engagement members of the trocar 125 and the stylet 130 are disengaged from each other), thereby enabling the trocar unit 105 and the stylet unit 110 to be selectively adjoined with and separated from each other.
- the one or more stylet engaging elements 140 are engaged with the one or more trocar engaging elements 145 (i.e., the mating engagement members of the trocar 125 and the stylet 130 are engaged with each other), thereby enabling inhibiting unrestricted axial displacement of the stylet 125 relative to the trocar unit 105 .
- the trocar unit 105 includes an adaptor 160 (e.g., a threaded mounting body such as a Leuer Lock).
- the adaptor 160 provides for attachment to a bonding material delivery device 161 such as a syringe (e.g., directly or via a piece of tubing).
- bonding material e.g., cement, adhesive or the like
- bonding material delivery device 151 may be dispensed from the bonding material delivery device 151 through the trocar unit 105 to a site of a sacral insufficiency fracture.
- the method 200 begins with the SI fracture patient 205 being placed in a prone position on an operating table 210 , as shown in FIG. 7 , and is then administered anesthesia.
- the operating table 210 is a radiolucent style of table—e.g., a Jackson radiolucent table.
- a collection of images are taken of the patient's skeletal anatomy 215 in the pelvic region (i.e., pelvic anatomy) to aid in performing treatment of the SI fracture F ( FIGS. 9 and 10 ).
- Such images are taken of an affected side of the sacrum to identify an intended entry point for insertion of the access device 100 .
- these views may include a lateral view ( FIG. 8 ), an inlet view ( FIG. 9 ), such as an AP view with 30 degree caudal angle, and an outlet view ( FIG. 10 ), such as an AP view with 30 degree cranial angle).
- FIG. 8 a lateral view
- an inlet view FIG. 9
- an outlet view FIG. 10
- FIG. 10 such as an AP view with 30 degree cranial angle
- a dorsal sacral line DSL and a superior alar line SAL in regard to the patient's skeletal anatomy are referenced for use during the surgical procedure (e.g., are marked ipsilaterally on the patient's skin at the lateral aspect of the buttock).
- the dorsal sacral line is comprised of the dorsal aspect of the five fused vertebrae that comprise the sacrum.
- the dense nature of this dorsal aspect of the sacrum forms a corresponding highly-visible line—i.e., represented by the dorsal sacral line DSL shown in FIG. 11 .
- the superior alar line is formed by the superior edge of the alar wings that project horizontally from the sacrum bilaterally.
- the dense nature of the superior edges of each alar wing will align to form a corresponding highly-visible line—i.e., represented by the superior alar line SAL shown in FIG. 11 .
- the dorsal sacral line and the superior alar line intersect, as shown, and they can be used to verify the surgeon has achieved a true lateral radiographic image and to perform required measurements for entry point targeting.”
- the intended entry point IEP is then also similarly referenced at a location approximately 2-4 cm inferior to the dorsal sacral line DSL and 2-4 cm posterior to the superior alar line SAL. After the area surrounding the intended entry point is prepped and draped in standard sterile fashion. the intended entry point IEP may again be verified via fluoroscopy.
- a puncture is made at the intended entry point IEP (e.g., with an 11 blade scalpel).
- lateral fluoroscopic guidance is then preferably used to begin placement of the access device 100 by passing a distal end portion 150 of the access device 100 through soft tissue of the patient toward the bone of the ilium wing I.
- preferred placement of the access device 100 is at the midportion between the dorsal sacral line DSL and the superior alar line SAL.
- the access device 100 is gently impacted (e.g., with a mallet) until good purchase between its distal end portion 150 and the ilium wing I is achieved. Additional inlet and outlet views are preferably obtained to verify appropriate trajectory of the access device 100 and to ensure avoidance of ventral breach of the sacrum S. While in outlet view, distal end portion 150 of the trocar unit 100 is gently urged farther until it traverses the sacroiliac joint SJ into the sacrum S. Continued urging of the distal end portion 150 of the access device 100 is carried out until it reaches a depth that approximately aligns with the S1 pedicle, which should be readily visualized.
- inlet and lateral views are preferably taken to ensure appropriate position of the distal end portion 150 of the access device 100 and to ensure absence of ventral or dorsal breach of the sacrum S.
- the access device 100 is placed from a lateral access point lateral to the gluteus muscle using lateral/inlet/outlet fluoroscopy views in sequence while guiding the access device 100 medially across the ilium/alar wing into the sacrum S.
- This placement approach results in placement of the distal end portion 150 of the access device 100 being in the region of the noted SI fracture.
- a bonding material e.g., cement such as methlymethacrylate polymer
- a bonding material is injected through the central passage 135 of the trocar unit 105 under live fluoroscopy after removal of the stylet unit 110 from within the central passage 135 .
- intermittent breaks in the bonding material delivery may be taken to obtain inlet and lateral fluoroscopic views to verify that none of the bonding material has exhibited extravasation beyond the sacral margins. Bonding material injection continues until visual confirmation of bonding material traversal of the SI fracture site indicated on pre-operative imaging has been achieved.
- Bonding material delivery is preferably performed under live fluoroscopy with intermittent images (e.g., lateral and inlet) to confirm absence of bonding material extravasation beyond the sacral confines. Additionally, the S1 foramen may be monitored (e.g., via outlet view) during injection to ensure no encroachment of the bonding material on the S1 foramen. Once adequate filling has been achieved, the stylet unit 110 is re-engaged with the trocar unit 105 to expel remaining cement preferably under live outlet fluoroscopy. The bonding material is allowed to sufficiently cure (e.g., approximately 1-2 minutes for methlymethacrylate polymer) and then the access device 100 is removed.
- intermittent images e.g., lateral and inlet
- the S1 foramen may be monitored (e.g., via outlet view) during injection to ensure no encroachment of the bonding material on the S1 foramen.
- the stylet unit 110 is re-engaged with the trocar unit 105 to expel remaining cement
- a rotatory manual injector syringe i.e., a bonding material delivery device
- the bonding material the trocar unit 105 includes an adaptor 160 that provides for attachment to the bonding material delivery device 161 either directly or via a conduit (e.g., a piece of tubing).
- a conduit e.g., a piece of tubing
- the central passage 135 of the trocar unit 105 may be lightly filled with saline to allow air to be expelled (e.g., via elevated intravenous (IV) extension tubing).
- a suitable visualization composition e.g., Isovue 200M
- Isovue 200M may first be injected under live fluoroscopy to monitor an expected filling by the bonding material.
Abstract
A method for treatment of a sacral insufficiency fracture comprises a plurality of steps. A step is performed for placing an access device within a patient. Such placing of the access device includes causing a distal end portion of the access device to traverse through a sacroiliac joint of the patient and to traverse into the patient's sacrum until the distal end portion of the access device is within a region of the sacrum where a sacral insufficiency fracture is located. Thereafter, a step is performed for delivering bonding material though a portion of the access device into the sacrum at the region thereof where the sacral insufficiency fracture is located.
Description
- The disclosures made herein relate generally to treatment techniques for spinal and pelvic ailments and, more particularly, to methods of treating sacral insufficiency fractures and devices for performing same.
- Sacral insufficiency fractures generally involve a non-displaced fracture of the sacrum. They are typically very painful, causing site-specific pain and leading to significant debility in patients. The underlying cause for such fractures is poor bone quality such as from a result of osteoporosis or osteopenia. Accordingly, sacral insufficiency fractures are most often seen in the elderly population. Although this type of fracture is often the result of trauma, lifting, or excessive activity, they also may occur with no clear inciting event.
- Non-surgical treatment for sacral insufficiency fractures involves prolonged bedrest, with the understanding that the fractures will eventually heal on their own. Unfortunately, prolonged bedrest has well-documented negative effects, including complications such as blood clots, muscle wasting, deconditioning, etc. An intermittently-used surgical treatment for sacral insufficiency fractures has been sacroplasty, which involves a radiologist performing a procedural variation of the more widely used vertebroplasty or kyphoplasty procedures in a CT-guided setting. Vertebroplasty and kyphoplasty procedures are used to treat vertebral body fractures. In this regard, sacroplasty generally requires significant planning which has been known to delay treatment, make it logistically/financially unviable, or both.
- Therefore, methods of surgical treatment for sacral insufficiency fractures that overcomes drawbacks associated with conventional surgical and non-surgical treatments would be advantageous, desirable and useful.
- Embodiments of the disclosures made herein are directed to methods of surgical treatment for sacral insufficiency fractures and devices used in such methods. Beneficially, these treatment methods are more attainable for surgeons already performing sacroiliac joint (SJ) fusions because it employs familiar radiological landmarks and because it is a more efficient technique for performing sacroplasty. Thus, because treatment methods in accordance with the disclosures made herein utilize only fluoroscopy and not a computerized tomography (CT) scanner or other type of imaging technology, the ability to schedule procedures for such treatment methods in an operating room (OR) or a procedure suite are much more cost-effective and are logistically much simpler—i.e., does not require services of a radiologist and CT scanner. The end result is that such treatment methods will allow more readily-available sacral fracture treatment for patients and ultimately allow faster alleviation of suffering and lead to better outcomes both short-term and long-term. Accordingly, methods of surgical treatment for sacral insufficiency fractures in accordance with embodiments of the disclosures made herein advantageously overcome drawbacks associated with conventional surgical and non-surgical treatments.
- In one or more embodiments of the disclosures made herein, a method for treatment of a sacral insufficiency fracture comprises a plurality of steps. A step is performed for placing an access device within a patient. Such placing of the access device includes causing a distal end portion of the access device to traverse through a sacroiliac joint of the patient and to traverse into the patient's sacrum until the distal end portion of the access device is within a region of the sacrum where a sacral insufficiency fracture is located. Thereafter, a step is performed for delivering bonding material though a portion of the access device into the sacrum at the region thereof where the sacral insufficiency fracture is located.
- In one or more embodiments of the disclosures made herein, an access device adapted for treatment of a skeletal fracture comprises a trocar having a central passage and a stylet having a portion thereof deposed within a central passage of the trocar. The distal end portion of the access device includes a distal end portion of the trocar. The stylet includes engagement structures that engage mating engagement structures of the trocar for maintaining the stylet in a fixed axial position within the central passage of the trocar when the mating engagement structures are in an engaged configuration and enabling the stylet to be removed from within the central passage of the trocar when the mating engagement structures are in a disengaged configuration.
- In one or more embodiments, placing the access device is performed using only fluoroscopy for visualizing guidance of the access device.
- In one or more embodiments, the method for treatment of the sacral insufficiency fracture further comprises identifying an intended entry point for the access device.
- In one or more embodiments, identifying the intended entry point includes determining a dorsal sacral line and a superior alar line in regard to the patient's pelvic anatomy.
- In one or more embodiments, the intended entry point is approximately 2-4 centimeters inferior to the dorsal sacral line and approximately 2-4 centimeters posterior to the superior alar line.
- In one or more embodiments, delivering the bonding material includes attaching a bonding material delivery device to a trocar of the access device and using the bonding material delivery device to inject the bonding material into the region of the sacrum where the sacral insufficiency fracture is located.
- In one or more embodiments, the access device includes mating engagement structures that maintaining the stylet in a fixed axial position within the central passage of the trocar when the mating engagement structures are in an engaged configuration and enabling the stylet to be removed from within the central passage of the trocar when the mating engagement structures are in a disengaged configuration.
- In one or more embodiments, placing the access device includes maintaining the trocar and stylet in the engaged configuration and removing the stylet from within the central passage of the trocar includes manipulating the trocar and stylet to be in the disengaged configuration.
- In one or more embodiments, the access device includes a trocar and a stylet having a portion thereof deposed within a central passage of the trocar, the distal end portion of the access device includes a distal end portion of the trocar and delivering the bonding material includes removing the stylet from within the central passage of the trocar after placing an access device and attaching a bonding material delivery device to a proximate end portion of the trocar removing the stylet from within the central passage of the trocar.
- In one or more embodiments, the method for treatment of the sacral insufficiency fracture further comprises inserting the stylet back into the central passage after injecting the bonding material and removing the access device from the patient after the bonding material has fully or partially cured.
- In one or more embodiments, the method for treatment of the sacral insufficiency fracture further comprises urging the distal end portion of the access device into fixed engagement with an ilium wing of the patient's pelvic anatomy and, in response to attaining fixed engagement with the ilium wing of the patient's pelvic anatomy, assessing at least one of inlet and outlet fluoroscopic views of the patient's pelvic anatomy to verify an intended trajectory of the distal end portion of the access device, and while viewing the distal end portion of the access device under live fluoroscopy, further urging the distal end portion of the access device until the distal end portion of the access device traverses the sacroiliac joint and protrudes into the sacrum.
- In one or more embodiments, the access device adapted for treatment of a skeletal fracture further comprises an adaptor configured for enabling attachment to the bonding material delivery device to the trocar to allow the bonding material to be delivered to an operative site through the central passage of the trocar.
- In one or more embodiments, the adapter is a threaded mounting body integral with a handle of the trocar.
- These and other objects, embodiments, advantages and/or distinctions of the present invention will become readily apparent upon further review of the following specification, associated drawings and appended claims.
-
FIG. 1 is a perspective view showing an access device in accordance with one or more embodiment of the disclosures made herein; -
FIG. 2 is an exploded view of the access device ofFIG. 1 ; -
FIG. 3 is a partial view of the access device ofFIG. 1 , where a stylet unit (i.e., stylet and attached handle) is in a release configuration relative to a trocar unit (i.e., a trocar and attached handle); -
FIG. 4 is a partial view of the access device ofFIG. 1 , where the stylet unit is in an engaged configuration relative to the trocar unit; -
FIG. 5 is a perspective view of the trocar unit; -
FIG. 6 is a cross-sectional view taken along the line 6-6 inFIG. 5 ; -
FIG. 7 is an illustrative view showing a patient in a prone position on an operating table; -
FIG. 8 is a lateral view of a pelvic portion of the patient's anatomy (i.e., pelvic anatomy); -
FIG. 9 is an inlet view of the pelvic portion of the patient's anatomy; -
FIG. 10 is an outlet view of the pelvic portion of the patient's anatomy; -
FIG. 11 is the lateral view of the pelvic portion of the patient's anatomy with access device entry point reference information shown; -
FIG. 12 is the inlet view of the pelvic portion of the patient's anatomy showing an SI fracture and an access device shown in a partially placed position; and -
FIG. 13 is the outlet view of the pelvic portion of the patient's anatomy showing the SI fracture and the access device shown in a partially placed position. - In general, embodiments of the disclosures made herein are directed to methods of surgical treatment for sacral insufficiency (SI) fractures and devices used in such methods. Because treatment methods in accordance with embodiments of the disclosures made herein preferably utilize only fluoroscopy, scheduling procedures for such treatment methods in an operating room (OR) or a procedure suite may be much more cost-effective and logistically much simpler. Accordingly, treatment methods in accordance with embodiments of the disclosures made herein allow for more readily-available sacral fracture treatment for patients and ultimately allow faster alleviation of suffering and lead to better outcomes both short-term and long-term.
- Treatment methods in accordance with embodiments of the disclosures made herein may involve use of an
access device 100 comprising atrocar unit 105 and astylet unit 110, as shown inFIGS. 1-6 . Thetrocar unit 105 has a trocarhandle 124 and atrocar 125 attached to thetrocar handle 124. Thestylet unit 110 has astylet handle 129 and astylet 130 attached tostylet handle 129. Acentral passage 135 extends through thetrocar handle 124 and thetrocar 125. Thestylet 130 is engageable within thecentral passage 135. Preferably, thestylet 130 has a length to where adistal end portion 150 of thestylet 130 extends beyond adistal end portion 155 of thetrocar 125 when thetrocar unit 105 and thestylet unit 110 are engaged with each other, as shown inFIG. 1 ). Although similar in design to vertebroplasty devices, thetrocar unit 105 is designed to allow access to deeper elements of the sacrum and better control of thetrocar 125 at deeper depths. For example, in preferred embodiments, thetrocar 125 may be about an 11 gauge in size with a length of about 9 inches. - The
trocar handle 124 and the stylet handle 129 may be jointly configured to selectively allow thetrocar unit 105 and thestylet unit 110 to be adjoined with each other (e.g., for inhibiting unrestricted axial displacement of thestylet 125 relative to the trocar unit 105) and to be separated from each other. For example, as best shown inFIGS. 3, 4 and 6 , the trocar handle 124 may have one or more stylet engaging elements 140 (e.g., protruding members) that may be selectively engage with one or more trocar engaging elements 145 (e.g., a recess or channel) of thestylet handle 129. In this respect, thestylet engaging elements 140 are engagement structures of thetrocar 125 and thetrocar engaging elements 145 are engagement structures of thestylet 130. When thetrocar handle 124 is in a disengaged configuration D relative to thestylet handle 129, the one or morestylet engaging elements 140 are disengaged from the one or more trocar engaging elements 145 (i.e., the mating engagement members of thetrocar 125 and thestylet 130 are disengaged from each other), thereby enabling thetrocar unit 105 and thestylet unit 110 to be selectively adjoined with and separated from each other. When thetrocar handle 124 is in an engaged configuration E relative to thestylet handle 129, the one or morestylet engaging elements 140 are engaged with the one or more trocar engaging elements 145 (i.e., the mating engagement members of thetrocar 125 and thestylet 130 are engaged with each other), thereby enabling inhibiting unrestricted axial displacement of thestylet 125 relative to thetrocar unit 105. - Preferably, as best shown in
FIGS. 5 and 6 , thetrocar unit 105 includes an adaptor 160 (e.g., a threaded mounting body such as a Leuer Lock). Theadaptor 160 provides for attachment to a bondingmaterial delivery device 161 such as a syringe (e.g., directly or via a piece of tubing). Through such attachment, bonding material (e.g., cement, adhesive or the like) may be dispensed from the bonding material delivery device 151 through thetrocar unit 105 to a site of a sacral insufficiency fracture. - Presented now is one specific embodiment of a SI fracture treatment method in accordance with the disclosures made herein (i.e., method 200), which utilizes the
access device 100. The method 200 begins with theSI fracture patient 205 being placed in a prone position on an operating table 210, as shown inFIG. 7 , and is then administered anesthesia. Preferably, the operating table 210 is a radiolucent style of table—e.g., a Jackson radiolucent table. - A collection of images are taken of the patient's
skeletal anatomy 215 in the pelvic region (i.e., pelvic anatomy) to aid in performing treatment of the SI fracture F (FIGS. 9 and 10 ). Such images are taken of an affected side of the sacrum to identify an intended entry point for insertion of theaccess device 100. Preferably, these views may include a lateral view (FIG. 8 ), an inlet view (FIG. 9 ), such as an AP view with 30 degree caudal angle, and an outlet view (FIG. 10 ), such as an AP view with 30 degree cranial angle). As shown inFIG. 11 , a dorsal sacral line DSL and a superior alar line SAL in regard to the patient's skeletal anatomy are referenced for use during the surgical procedure (e.g., are marked ipsilaterally on the patient's skin at the lateral aspect of the buttock). The dorsal sacral line is comprised of the dorsal aspect of the five fused vertebrae that comprise the sacrum. In a true lateral projection radiographic image (i.e., fluoroscopy), the dense nature of this dorsal aspect of the sacrum forms a corresponding highly-visible line—i.e., represented by the dorsal sacral line DSL shown inFIG. 11 . The superior alar line is formed by the superior edge of the alar wings that project horizontally from the sacrum bilaterally. In a true lateral radiographic image, the dense nature of the superior edges of each alar wing will align to form a corresponding highly-visible line—i.e., represented by the superior alar line SAL shown inFIG. 11 . The dorsal sacral line and the superior alar line intersect, as shown, and they can be used to verify the surgeon has achieved a true lateral radiographic image and to perform required measurements for entry point targeting.” The intended entry point IEP is then also similarly referenced at a location approximately 2-4 cm inferior to the dorsal sacral line DSL and 2-4 cm posterior to the superior alar line SAL. After the area surrounding the intended entry point is prepped and draped in standard sterile fashion. the intended entry point IEP may again be verified via fluoroscopy. - Next, a puncture is made at the intended entry point IEP (e.g., with an 11 blade scalpel). Referring to
FIGS. 12 and 13 , lateral fluoroscopic guidance is then preferably used to begin placement of theaccess device 100 by passing adistal end portion 150 of theaccess device 100 through soft tissue of the patient toward the bone of the ilium wing I. As discussed above, preferred placement of theaccess device 100 is at the midportion between the dorsal sacral line DSL and the superior alar line SAL. Once thedistal end portion 150 of theaccess device 100 is at the bone of the ilium wing I, theaccess device 100 is gently impacted (e.g., with a mallet) until good purchase between itsdistal end portion 150 and the ilium wing I is achieved. Additional inlet and outlet views are preferably obtained to verify appropriate trajectory of theaccess device 100 and to ensure avoidance of ventral breach of the sacrum S. While in outlet view,distal end portion 150 of thetrocar unit 100 is gently urged farther until it traverses the sacroiliac joint SJ into the sacrum S. Continued urging of thedistal end portion 150 of theaccess device 100 is carried out until it reaches a depth that approximately aligns with the S1 pedicle, which should be readily visualized. Repeat inlet and lateral views are preferably taken to ensure appropriate position of thedistal end portion 150 of theaccess device 100 and to ensure absence of ventral or dorsal breach of the sacrum S. In this manner, theaccess device 100 is placed from a lateral access point lateral to the gluteus muscle using lateral/inlet/outlet fluoroscopy views in sequence while guiding theaccess device 100 medially across the ilium/alar wing into the sacrum S. This placement approach results in placement of thedistal end portion 150 of theaccess device 100 being in the region of the noted SI fracture. - Once correct placement of the
access device 100 relative to the bony confines of the sacrum S is verified (e.g., by 3 views of fluoroscopy—lateral, outlet and inlet), a bonding material (e.g., cement such as methlymethacrylate polymer) is injected through thecentral passage 135 of thetrocar unit 105 under live fluoroscopy after removal of thestylet unit 110 from within thecentral passage 135. As filling of sacral fracture site begins, intermittent breaks in the bonding material delivery may be taken to obtain inlet and lateral fluoroscopic views to verify that none of the bonding material has exhibited extravasation beyond the sacral margins. Bonding material injection continues until visual confirmation of bonding material traversal of the SI fracture site indicated on pre-operative imaging has been achieved. Bonding material delivery is preferably performed under live fluoroscopy with intermittent images (e.g., lateral and inlet) to confirm absence of bonding material extravasation beyond the sacral confines. Additionally, the S1 foramen may be monitored (e.g., via outlet view) during injection to ensure no encroachment of the bonding material on the S1 foramen. Once adequate filling has been achieved, thestylet unit 110 is re-engaged with thetrocar unit 105 to expel remaining cement preferably under live outlet fluoroscopy. The bonding material is allowed to sufficiently cure (e.g., approximately 1-2 minutes for methlymethacrylate polymer) and then theaccess device 100 is removed. - In one or more embodiments, a rotatory manual injector syringe (i.e., a bonding material delivery device) may be used to inject the bonding material. As discussed above, the bonding material the
trocar unit 105 includes anadaptor 160 that provides for attachment to the bondingmaterial delivery device 161 either directly or via a conduit (e.g., a piece of tubing). Prior to attachment of the bonding material delivery device to thetrocar unit 105, thecentral passage 135 of thetrocar unit 105 may be lightly filled with saline to allow air to be expelled (e.g., via elevated intravenous (IV) extension tubing). Optionally, a suitable visualization composition (e.g., Isovue 200M) may first be injected under live fluoroscopy to monitor an expected filling by the bonding material. - Although the invention has been described with reference to several exemplary embodiments, it is understood that the words that have been used are words of description and illustration, rather than words of limitation. Changes may be made within the purview of the appended claims, as presently stated and as amended, without departing from the scope and spirit of the invention in all its aspects. Although the invention has been described with reference to particular means, materials and embodiments, the invention is not intended to be limited to the particulars disclosed; rather, the invention extends to all functionally equivalent technologies, structures, methods and uses such as are within the scope of the appended claims.
Claims (20)
1. A method for treatment of a sacral insufficiency fracture, comprising:
placing an access device within a patient, wherein said placing includes causing a distal end portion of the access device to traverse through a sacroiliac joint of the patient and to traverse into the patient's sacrum until the distal end portion of the access device is within a region of the sacrum where a sacral insufficiency fracture is located; and
delivering bonding material though a portion of the access device into the sacrum at the region thereof where the sacral insufficiency fracture is located.
2. The method of claim 1 wherein said placing includes using only fluoroscopy for visualizing guidance of the access device.
3. The method of claim 2 , further comprising:
identifying an intended entry point for the access device, wherein said identifying includes determining a dorsal sacral line and a superior alar line in regard to the patient's pelvic anatomy;
wherein the intended entry point is approximately 2-4 centimeters inferior to the dorsal sacral line and approximately 2-4 centimeters posterior to the superior alar line; and
wherein placing the access device includes inserting the distal end portion of the access device through the intended entry point.
4. The method of claim 1 wherein said delivering includes:
attaching a bonding material delivery device to a trocar of the access device; and
using the bonding material delivery device to inject the bonding material into the region of the sacrum where the sacral insufficiency fracture is located.
5. The method of claim 4 wherein:
the access device includes mating engagement structures that maintaining the stylet in a fixed axial position within the central passage of the trocar when the mating engagement structures are in an engaged configuration and enabling the stylet to be removing stylet from within the central passage of the trocar when the mating engagement structures are in a disengaged configuration;
placing the access device includes maintaining the trocar and stylet in the engaged configuration; and
removing the stylet from within the central passage of the trocar includes manipulating the trocar and stylet to be in the disengaged configuration.
6. The method of claim 1 wherein:
the access device includes a trocar and a stylet having a portion thereof deposed within a central passage of the trocar;
the distal end portion of the access device includes a distal end portion of the trocar; and
said delivering includes removing the stylet from within the central passage of the trocar after placing an access device and attaching a bonding material delivery device to a proximate end portion of the trocar removing the stylet from within the central passage of the trocar.
7. The method of claim 1 wherein:
the access device includes a trocar and a stylet having a portion thereof deposed within a central passage of the trocar;
the distal end portion of the access device includes a distal end portion of the trocar; and
said delivering includes removing stylet from within the central passage of the trocar while the distal end portion of the trocar remains positioned within the region of the sacrum where the sacral insufficiency fracture is located and attaching a bonding material delivery device to a trocar of the access device for enabling delivery of bonding material from the bonding material delivery device into the sacrum through the central passage of the of the trocar.
8. The method of claim 7 , further comprising:
inserting the stylet back into the central passage after injecting the bonding material; and
removing the access device from the patient after the bonding material has one of fully and partially cured.
9. The method of claim 8 wherein:
the access device includes mating engagement structures that maintaining the stylet in a fixed axial position within the central passage of the trocar when the mating engagement structures are in an engaged configuration and enabling the stylet to be removing stylet from within the central passage of the trocar when the mating engagement structures are in a disengaged configuration;
placing the access device includes maintaining the trocar and stylet in the engaged configuration; and
removing the stylet from within the central passage of the trocar includes manipulating the trocar and stylet to be in the disengaged configuration.
10. The method of claim 9 , further comprising:
identifying an intended entry point for the access device, wherein said identifying includes determining a dorsal sacral line and a superior alar line in regard to the patient's pelvic anatomy;
wherein the intended entry point is approximately 2-4 centimeters inferior to the dorsal sacral line and approximately 2-4 centimeters posterior to the superior alar line; and
wherein placing the access device includes inserting the distal end portion of the access device through the intended entry point.
11. The method of claim 1 , further comprising:
identifying an intended entry point for the access device, wherein said identifying includes determining a dorsal sacral line and a superior alar line in regard to the patient's pelvic anatomy;
wherein the intended entry point is approximately 2-4 centimeters inferior to the dorsal sacral line and approximately 2-4 centimeters posterior to the superior alar line; and
wherein placing the access device includes inserting the distal end portion of the access device through the intended entry point.
12. The method of claim 11 wherein placing the access device includes:
urging the distal end portion of the access device into fixed engagement with an ilium wing of the patient's pelvic anatomy;
in response to attaining fixed engagement with the ilium wing of the patient's pelvic anatomy, assessing at least one of inlet and outlet fluoroscopic views of the patient's pelvic anatomy to verify an intended trajectory of the distal end portion of the access device; and
while viewing the distal end portion of the access device under live fluoroscopy, further urging the distal end portion of the access device until the distal end portion of the access device traverses the sacroiliac joint and protrudes into the sacrum.
13. The method of claim 12 wherein said placing includes using only fluoroscopy for visualizing guidance of the access device.
14. The method of claim 12 wherein:
the access device includes a trocar and a stylet having a portion thereof deposed within a central passage of the trocar;
the distal end portion of the access device includes a distal end portion of the trocar; and
said delivering includes removing stylet from within the central passage of the trocar while the distal end portion of the trocar remains positioned within the region of the sacrum where the sacral insufficiency fracture is located and attaching a bonding material delivery device to a trocar of the access device for enabling delivery of bonding material from the bonding material delivery device into the sacrum through the central passage of the of the trocar.
15. The method of claim 14 , further comprising:
inserting the portion of the stylet back into the central passage after injecting the bonding material; and
removing the access device from the patient after the bonding material has one of fully and partially cured.
16. The method of claim 15 wherein:
the access device includes mating engagement structures that maintaining the stylet in a fixed axial position within the central passage of the trocar when the mating engagement structures are in an engaged configuration and enabling the stylet to be removing stylet from within the central passage of the trocar when the mating engagement structures are in a disengaged configuration;
placing the access device includes maintaining the trocar and stylet in the engaged configuration; and
removing the stylet from within the central passage of the trocar includes manipulating the trocar and stylet to be in the disengaged configuration.
17. The method of claim 16 wherein said placing includes using only fluoroscopy for visualizing guidance of the access device.
18. An access device adapted for treatment of a skeletal fracture, comprising:
a trocar having a central passage; and
a stylet having a portion thereof deposed within a central passage of the trocar, wherein the distal end portion of the access device includes a distal end portion of the trocar, wherein the stylet includes engagement structures that engage mating engagement structures of the trocar for maintaining the stylet in a fixed axial position within the central passage of the trocar when the mating engagement structures are in an engaged configuration and enabling the stylet to be removing stylet from within the central passage of the trocar when the mating engagement structures are in a disengaged configuration.
19. The access device of claim 17 , further comprising:
an adaptor configured for enabling attachment to a bonding material delivery device to the trocar to allow a bonding material to be delivered to an operative site through the central passage of the trocar.
20. The access device of claim 18 wherein the adapter is a threaded mounting body.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/744,510 US11813009B1 (en) | 2022-05-13 | 2022-05-13 | Methods of treating sacral insufficiency fractures and devices for performing same |
US18/482,218 US20240032975A1 (en) | 2022-05-13 | 2023-10-06 | Methods of treating sacral insufficiency fractures and devices for performing same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/744,510 US11813009B1 (en) | 2022-05-13 | 2022-05-13 | Methods of treating sacral insufficiency fractures and devices for performing same |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/482,218 Continuation US20240032975A1 (en) | 2022-05-13 | 2023-10-06 | Methods of treating sacral insufficiency fractures and devices for performing same |
Publications (2)
Publication Number | Publication Date |
---|---|
US11813009B1 US11813009B1 (en) | 2023-11-14 |
US20230363809A1 true US20230363809A1 (en) | 2023-11-16 |
Family
ID=88700026
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/744,510 Active 2042-06-01 US11813009B1 (en) | 2022-05-13 | 2022-05-13 | Methods of treating sacral insufficiency fractures and devices for performing same |
US18/482,218 Pending US20240032975A1 (en) | 2022-05-13 | 2023-10-06 | Methods of treating sacral insufficiency fractures and devices for performing same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/482,218 Pending US20240032975A1 (en) | 2022-05-13 | 2023-10-06 | Methods of treating sacral insufficiency fractures and devices for performing same |
Country Status (1)
Country | Link |
---|---|
US (2) | US11813009B1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6575919B1 (en) * | 1999-10-19 | 2003-06-10 | Kyphon Inc. | Hand-held instruments that access interior body regions |
US9974573B2 (en) * | 2014-10-24 | 2018-05-22 | Mis Ip Holdings Llc | Minimally invasive approaches, methods and apparatuses to accomplish sacroiliac fusion |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7641657B2 (en) | 2003-06-10 | 2010-01-05 | Trans1, Inc. | Method and apparatus for providing posterior or anterior trans-sacral access to spinal vertebrae |
US20070282447A1 (en) | 2006-06-01 | 2007-12-06 | Yedlicka Joseph W | Fluid-transfer device, vertebral treatment device,system and methods of use |
US8480673B2 (en) | 2006-06-01 | 2013-07-09 | Osteo Innovations Llc | Cavity creation device and methods of use |
US20080140082A1 (en) | 2006-07-17 | 2008-06-12 | Eren Erdem | Kit and methods for medical procedures within a sacrum |
US10596004B2 (en) | 2010-01-13 | 2020-03-24 | Jcbd, Llc | Spinopelvic fixation technology |
US20120022568A1 (en) | 2010-03-03 | 2012-01-26 | Orthovita, Inc. | Instrument for Use in Bone and Method of Use |
JP5633320B2 (en) | 2010-11-05 | 2014-12-03 | 株式会社リコー | Drawing image sharing device |
ES2773544T3 (en) | 2013-04-08 | 2020-07-13 | Inossia Ab | Acrylic cements for bone augmentation |
US10064670B2 (en) | 2014-05-12 | 2018-09-04 | DePuy Synthes Products, Inc. | Sacral fixation system |
EP3142578B1 (en) | 2014-05-12 | 2019-03-13 | DePuy Synthes Products, Inc. | Sacral fixation system |
US9801546B2 (en) | 2014-05-27 | 2017-10-31 | Jcbd, Llc | Systems for and methods of diagnosing and treating a sacroiliac joint disorder |
US11284798B2 (en) | 2014-05-27 | 2022-03-29 | Jcbd, Llc | Systems for and methods of diagnosing and treating a sacroiliac joint disorder |
US10603055B2 (en) | 2017-09-15 | 2020-03-31 | Jcbd, Llc | Systems for and methods of preparing and fusing a sacroiliac joint |
WO2021050767A1 (en) | 2019-09-12 | 2021-03-18 | Relievant Medsystems, Inc. | Systems and methods for tissue modulation |
-
2022
- 2022-05-13 US US17/744,510 patent/US11813009B1/en active Active
-
2023
- 2023-10-06 US US18/482,218 patent/US20240032975A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6575919B1 (en) * | 1999-10-19 | 2003-06-10 | Kyphon Inc. | Hand-held instruments that access interior body regions |
US9974573B2 (en) * | 2014-10-24 | 2018-05-22 | Mis Ip Holdings Llc | Minimally invasive approaches, methods and apparatuses to accomplish sacroiliac fusion |
Non-Patent Citations (1)
Title |
---|
Three-dimensional C-arm computed tomography reformation combined with fluoroscopic-guided sacroplasty for sacral metastases, Support Care Cancer (2012) 20: pages 2083-2088. (Year: 2012) * |
Also Published As
Publication number | Publication date |
---|---|
US11813009B1 (en) | 2023-11-14 |
US20240032975A1 (en) | 2024-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009543671A (en) | Kit and method for medical procedures within the sacrum | |
Yukawa et al. | Cervical pedicle screw fixation in 100 cases of unstable cervical injuries: pedicle axis views obtained using fluoroscopy | |
US7922690B2 (en) | Curable material delivery device | |
US6993374B2 (en) | Instrumentation and method for mounting a surgical navigation reference device to a patient | |
JP2007511324A (en) | Windowed bone tap and method | |
Deen et al. | Balloon kyphoplasty for treatment of sacral insufficiency fractures: report of three cases | |
Costa et al. | Management of C1–2 traumatic fractures using an intraoperative 3D imaging–based navigation system | |
Li et al. | A novel approach for percutaneous vertebroplasty based on preoperative computed tomography–based three-dimensional model design | |
Zeng et al. | Novel targeted puncture technique for percutaneous transforaminal endoscopic lumbar discectomy reduces X-ray exposure | |
Jin et al. | Clinical and radiologic outcomes of robot-assisted kyphoplasty versus fluoroscopy-assisted kyphoplasty in the treatment of osteoporotic vertebral compression fractures: A retrospective comparative study | |
US11813009B1 (en) | Methods of treating sacral insufficiency fractures and devices for performing same | |
Loizides et al. | Ultrasound-guided injections in the middle and lower cervical spine | |
JP2017516626A (en) | Resection needle kit with resection cannula and insertion tube | |
US20080021312A1 (en) | Needle targeting device | |
Plaikner et al. | Ultrasound-guided versus computed tomography-controlled periradicular injections of the first sacral nerve: a prospective randomized clinical trial | |
Ziu et al. | Stereotactic vertebroplasty for spinal metastases with multilevel bilateral pedicle fractures: a technical note | |
Betts | Vertebroplasty of the first sacral vertebra | |
Becker et al. | The technique of balloon kyphoplasty | |
Judy et al. | Pearls and pitfalls of posterior superior iliac spine reference frame placement for spinal navigation: cadaveric series | |
Barr et al. | Extreme vertebroplasty: techniques for treating difficult lesions | |
Heini et al. | Balloon kyphoplasty and lordoplasty | |
Perforation | Vertebral Body Perforation (Percutaneous Transpedicular | |
Le Corroller | Bone Biopsy | |
Bierschneider et al. | Minimally invasive vertebral augmentation techniques in osteoporotic fractures | |
Ivanov et al. | Neuronavigation in the percutaneous treatment of trigeminal neuralgia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |